Form 8-K - Current report:
SEC Accession No. 0001935979-24-000011
Filing Date
2024-02-29
Accepted
2024-02-29 16:16:45
Documents
15
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20240229.htm   iXBRL 8-K 23933
2 EX-99.1 a2023q4bhvnltdearningsprex.htm EX-99.1 175899
  Complete submission text file 0001935979-24-000011.txt   345943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20240229.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20240229_lab.xml EX-101.LAB 23802
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20240229_pre.xml EX-101.PRE 12510
17 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20240229_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 24703883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)